The DOI matches its Crossref record; 35 of the 35 references it cites were found in a registry or an index.
Assessment of Mitochondrial Toxicity in Human Cells Treated with Tenofovir: Comparison with Other Nucleoside Reverse Transcriptase Inhibitors
Open accessAbstract
Drug-associated dysfunction of mitochondria is believed to play a role in the etiology of the various adverse symptoms that occur in human immunodeficiency virus (HIV)-infected patients treated with the nucleoside reverse transcriptase inhibitors (NRTIs). Tenofovir, a nucleotide analog recently approved for use in the treatment of HIV infection, was evaluated in vitro for its potential to cause mitochondrial toxicity and was compared to currently used NRTIs. Treatment with tenofovir (3 to 300 μM) for up to 3 weeks produced no significant changes in mitochondrial DNA (mtDNA) levels in human hepatoblastoma (HepG2) cells, skeletal muscle cells (SkMCs), or renal proximal tubule epithelial cells. The potencies of inhibition of mtDNA synthesis by the NRTIs tested were zalcitabine (ddC) > didanosine (ddI) > stavudine > zidovudine (ZDV) > lamivudine = abacavir = tenofovir, with comparable relative effects in the three cell types. Unlike ddC and ddI, tenofovir did not affect cellular expression of COX II and COX IV, two components of the mitochondrial cytochrome c oxidase complex. Lactate production was elevated by less than 20% in HepG2 cells or SkMCs following treatment with 300 μM tenofovir. In contrast, lactate synthesis increased by >200% in the presence of 300 μM ZDV. Thus, treatment of various human cell types with tenofovir at concentrations that greatly exceed those required for it both to have in vitro anti-HIV type 1 activity in peripheral blood mononuclear cells (50% effective concentration, 0.2 μM) and to achieve therapeutically relevant levels in plasma (maximum concentrations in plasma, 0.8 to 1.3 μM) is not associated with mitochondrial toxicity.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Adverse effects of reverse transcriptase inhibitors: mitochondrial toxicity as common pathway
Brinkman, K., ter Hofstede, H. J. M., Burger, D. M., Smeitink, J. A. M., & Koopmans, P. P. (1998) · AIDS · doi:10.1097/00002030-199814000-00004 · Cited by 847
Mitochondrial Myopathy Caused by Long-Term Zidovudine Therapy
Dalakas, M. C., Illa, I., Pezeshkpour, G. H., Laukaitis, J. P., Cohen, B., & Griffin, J. L. (1990) · New England Journal of Medicine · doi:10.1056/nejm199004193221602 · Cited by 844
Mitochondrial toxicity of antiviral drugs
Lewis, W., & Dalakas, M. C. (1995) · Nature Medicine · doi:10.1038/nm0595-417 · Cited by 770
McKenzie, R., Fried, M. W., Sallie, R., Conjeevaram, H., Di Bisceglie, A. M., Park, Y., Savarese, B., Kleiner, D., Tsokos, M., Luciano, C., et al. (1995) · New England Journal of Medicine · doi:10.1056/nejm199510263331702 · Cited by 616
Kakuda, T. N. (2000) · Clinical Therapeutics · doi:10.1016/s0149-2918(00)90004-3 · Cited by 612
Depletion of muscle mitochondrial DNA in AIDS patients with zidovudine-induced myopathy
Arnaudo, E., Shanske, S., DiMauro, S., Schon, E. A., Moraes, C. T., Schon, E. A., & Dalakas, M. (1991) · The Lancet · doi:10.1016/0140-6736(91)91294-5 · Cited by 505
CROSSTALK BETWEEN NUCLEAR AND MITOCHONDRIAL GENOMES
Poyton, R. O., & McEwen, J. E. (1996) · Annual Review of Biochemistry · doi:10.1146/annurev.bi.65.070196.003023 · Cited by 505
Effects of antiviral nucleoside analogs on human DNA polymerases and mitochondrial DNA synthesis
Martin, J. L., Brown, C. E., Matthews-Davis, N., & Reardon, J. E. (1994) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.38.12.2743 · Cited by 343
Barditch-Crovo, P., Deeks, S. G., Collier, A., Safrin, S., Coakley, D. F., Miller, M., Kearney, B. P., Coleman, R. L., Lamy, P. D., Kahn, J. O., et al. (2001) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.45.10.2733-2739.2001 · Cited by 330
Chen, C. H., Vazquez-Padua, M., & Cheng, Y. C. (1991) · Molecular Pharmacology · doi:10.1016/s0026-895x(25)11067-5 · Cited by 296
Cihlar, T., Ho, E. S., Lin, D. C., & Mulato, A. S. (2001) · Nucleosides, Nucleotides and Nucleic Acids · doi:10.1081/ncn-100002341 · Cited by 241
Self-citationAssembly of cytochrome‐c oxidase in cultured human cells
Nijtmans, L. G. J., Taanman, J., Muijsers, A. O., Speijer, D., & Van den Bogert, C. (1998) · European Journal of Biochemistry · doi:10.1046/j.1432-1327.1998.2540389.x · Cited by 241
Lactic Acidosis and Hepatic Steatosis Associated with Use of Stavudine: Report of Four Cases
Miller, K. D., Cameron, M., Wood, L. V., Dalakas, M. C., & Kovacs, J. A. (2000) · Annals of Internal Medicine · doi:10.7326/0003-4819-133-3-200008010-00010 · Cited by 211
Lewis, W., Gonzalez, B., Chomyn, A., & Papoian, T. (1992) · Journal of Clinical Investigation · doi:10.1172/jci115722 · Cited by 208
Cells depleted of mitochondrial DNA (p0) yield insight into physiological mechanisms
(1999) · FEBS Letters · doi:10.1016/s0014-5793(99)00783-8 · Cited by 198
Moyle, G. (2000) · Clinical Therapeutics · doi:10.1016/s0149-2918(00)80064-8 · Cited by 193
de la Asunción, J. G., del Olmo, M. L., Sastre, J., Millán, A., Pellín, A., Pallardó, F. V., & Viña, J. (1998) · Journal of Clinical Investigation · doi:10.1172/jci1418 · Cited by 186
Benbrik, E., Chariot, P., Bonavaud, S., Ammi-Saı̈d, M., Frisdal, E., Rey, C., Gherardi, R., & Barlovatz-Meimon, G. (1997) · Journal of the Neurological Sciences · doi:10.1016/s0022-510x(97)05376-8 · Cited by 184
Perry, C. M., & Faulds, D. (1997) · Drugs · doi:10.2165/00003495-199753040-00008 · Cited by 171
Lewis, W., Levine, E. S., Griniuviene, B., Tankersley, K. O., Colacino, J. M., Sommadossi, J. P., Watanabe, K. A., & Perrino, F. W. (1996) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.93.8.3592 · Cited by 168
A Missense Mutation of Cytochrome Oxidase Subunit II Causes Defective Assembly and Myopathy
Rahman, S., Taanman, J., Cooper, J. A. D., Nelson, I. P., Hargreaves, I., Meunier, B., Hanna, M. G., García, J. J., Capaldi, R., Lake, B. D., et al. (1999) · The American Journal of Human Genetics · doi:10.1086/302590 · Cited by 157
Medina, D. J., Tsai, C. H., Hsiung, G. D., & Cheng, Y. C. (1994) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.38.8.1824 · Cited by 136
Fulminant hepatitis with severe lactate acidosis in HIV‐infected patients on didanosine therapy
Bissuel, F., Bruneel, F., Habersetzer, F., CHASSARD, D., Cotte, L., Chevallier, M., Bernuau, J., Lucet, J. C., & TREPO, C. G. (1994) · Journal of Internal Medicine · doi:10.1111/j.1365-2796.1994.tb01088.x · Cited by 135
Sundar, K., Suarez, M., Banogon, P. E., & Shapiro, J. M. (1997) · Critical Care Medicine · doi:10.1097/00003246-199708000-00034 · Cited by 130
Cihlář, T., Birkuš, G., Greenwalt, D. E., & Hitchcock, M. J. M. (2002) · Antiviral Research · doi:10.1016/s0166-3542(01)00210-8 · Cited by 123
Self-citationCui, L., Yoon, S.-S., Schinazi, R. F., & Sommadossi, J. (1995) · Journal of Clinical Investigation · doi:10.1172/jci117698 · Cited by 120
Differential Effects of Antiretroviral Nucleoside Analogs on Mitochondrial Function in HepG2 Cells
Pan-Zhou, X.-R., Cui, L., Zhou, X., Sommadossi, J., & Darley-Usmar, V. M. (2000) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.44.3.496-503.2000 · Cited by 117
Marusich, M. F., Robinson, B. H., Taanman, J., Kim, S. J., Schillace, R. V., Smith, J. L., & Capaldi, R. (1997) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/s0925-4439(97)00061-6 · Cited by 111
Effect of Nucleoside Analogs on Neurite Regeneration and Mitochondrial DNA Synthesis in PC-12 Cells
Cui, L., Locatelli, L. D., Xie, M., & Sommadossi, J. (1997) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(24)36520-6 · Cited by 105
Cytochrome c oxidase: structure, function, and membrane topology of the polypeptide subunits
Cooper, C. E., Nicholls, P. J., & Freedman, J. A. (1991) · Biochemistry and Cell Biology · doi:10.1139/o91-089 · Cited by 94
Zidovudine (Azt) Causes An Oxidation of Mitochondrial Dna in Mouse Liver
de la Asunción, J. G., del Olmo, M. L., Sastre, J., Pallardó, F. V., & Viña, J. (1999) · Hepatology · doi:10.1002/hep.510290353 · Cited by 86
Lewis, W., Meyer, R. R., Simpson, J. F., Colacino, J. M., & Perrino, F. W. (1994) · Biochemistry · doi:10.1021/bi00252a030 · Cited by 80
Wang, J., & Eriksson, S. (1996) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.40.6.1555 · Cited by 66
Effect of β-enantiomeric and racemic nucleoside analogues on mitochondrial functions in HepG2 cells
Cui, L., Schinazi, R. F., Gosselin, G., Imbach, J., Chu, C. K., Rando, R. F., Revankar, G. R., & Sommadossi, J. (1996) · Biochemical Pharmacology · doi:10.1016/s0006-2952(96)00562-x · Cited by 52
Cihlář, T., & Chen, M. (1997) · Antiviral chemistry & chemotherapy · doi:10.1177/095632029700800302 · Cited by 44
Cited by
Mitochondrial toxicity of nrti antiviral drugs: an integrated cellular perspective
Lewis, W., Day, B. J., & Copeland, W. C. (2003) · Nature Reviews Drug Discovery · doi:10.1038/nrd1201 · Cited by 498
Antiviral Drug-Induced Nephrotoxicity
Izzedine, H., Launay-Vacher, V., & Deray, G. (2005) · American Journal of Kidney Diseases · doi:10.1053/j.ajkd.2005.02.010 · Cited by 423
The significance of mitochondrial toxicity testing in drug development
Dykens, J. A., & Will, Y. (2007) · Drug Discovery Today · doi:10.1016/j.drudis.2007.07.013 · Cited by 416
Ray, A. S., Fordyce, M. W., & Hitchcock, M. J. M. (2016) · Antiviral Research · doi:10.1016/j.antiviral.2015.11.009 · Cited by 392
Self-citationNucleoside and nucleotide HIV reverse transcriptase inhibitors: 25 years after zidovudine
Cihlar, T., & Ray, A. S. (2010) · Antiviral Research · doi:10.1016/j.antiviral.2009.09.014 · Cited by 375
Self-citation
Metadata
- Authors
- Birkus, G., Hitchcock, M. J. M., & Cihlar, T.
- Venue
- Antimicrobial Agents and Chemotherapy
- Publisher
- American Society for Microbiology
- Published
- 2002-03
- Volume
- 46
- Issue
- 3
- Pages
- 716-723
- ISSN
- 0066-4804 (ISSN-L)
- 1098-6596
- OpenAlex
- W2126327126
- Cited by
- 441
- References
- 35
- FWCI
- 22.43
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.